Drug: Nabilone: chronic pain clinical trials
Registry records that list "Drug: Nabilone" as an intervention. Being studied does not mean an intervention works or is approved.
3
Trials with Canadian sites
0
Recruiting in Canada
3
Registry records in total
Trials in Canada
3 trials, 0 recruiting or not yet recruiting. Recruiting first.
| Phase | Provinces | ||||
|---|---|---|---|---|---|
| Nabilone Use For Acute Pain in Inflammatory Bowel Disease Patients NCT03422861 | Unknown status | Not applicable | Ontario | Samuel Lunenfeld Research Institute, Mount Sinai Hospital | 2023-12 |
| Nabilone Versus Amitriptyline in Improving Quality of Sleep in Patients With Fibromyalgia NCT00381199 | Completed | Not applicable | Quebec | McGill University Health Centre/Research Institute of the McGill University Health Centre | 2006-04 |
| Use of the Cannabinoid Nabilone for the Promotion of Sleep in Chronic, Non-Malignant Pain Patients NCT00384410 | Unknown status | Phase 2 | Ontario | University Health Network, Toronto | 2005-12 |
Trials worldwide (outside Canada)
No other registry records list this intervention.
Conditions studied with this intervention
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status.